Zijin powder in inhibiting H22 mice solid and ascites liver cancer: experimental study / 中国中药杂志
China Journal of Chinese Materia Medica
;
(24): 1346-1348, 2005.
Article
in Chinese
| WPRIM
| ID: wpr-239681
ABSTRACT
<p><b>OBJECTIVE</b>To observe the rate of Zijin powder in inhibiting H22 mice solid and ascites liver cancer and the relation between quatity and effect.</p><p><b>METHOD</b>The Kunming mics, transplanted by H22 liver cells, were divided into a model group, a cyclophosphamide group and three groups of Zijin powder in high dose, medium dose, and low dose. Then observation was made on the rate of Cancer.</p><p><b>RESULT</b>The inhibiting rates of Zijin powder of three groups (high dose group, medium dose group and low dose group) for H22 mice solid liver cancer were 30.8%, 38.31% and 48.59% respectivily. The inhibiting rates of three groups of Zijin powder (low dose group, medium dose and high dose group) for H22 mice ascites liver cancer were 6.77%, 15.59% and 14.90 % respectivily.</p><p><b>CONCLUSION</b>Zijin powder has better effect on H22 mice solid liver cancer, and its effect is greatly increasing with the increased dosage.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pharmacology
/
Powders
/
Drugs, Chinese Herbal
/
Random Allocation
/
Therapeutic Uses
/
Dose-Response Relationship, Drug
/
Drug Therapy
/
Liver Neoplasms
/
Phytotherapy
/
Antineoplastic Agents, Phytogenic
Type of study:
Controlled clinical trial
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
Chinese
Journal:
China Journal of Chinese Materia Medica
Year:
2005
Type:
Article
Similar
MEDLINE
...
LILACS
LIS